So Yeon Park
Researcher Next ID · RN-036690
Researcher · Biochemistry, Genetics and Molecular Biology
Seoul, South Korea
- Works count
- 782
- Citation count
- 18,762
- H-index
- 69
- i10-index
- 340
Research interests
Publications
HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation
Journal of Pathology and Translational Medicine · 2019 · https://doi.org/10.4132/jptm.2019.11.03
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition
Cancer Discovery · 2017 · https://doi.org/10.1158/2159-8290.cd-17-0222
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer
Nature Genetics · 2015 · https://doi.org/10.1038/ng.3391
Expression of epithelial-mesenchymal transition–related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome
Human Pathology · 2015 · https://doi.org/10.1016/j.humpath.2015.05.010
High EGFR gene copy number predicts poor outcome in triple-negative breast cancer
Modern Pathology · 2014 · https://doi.org/10.1038/modpathol.2013.251
Histological improvement following administration of autologous bone marrow‐derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study
Liver International · 2013 · https://doi.org/10.1111/liv.12218
Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
British Journal of Cancer · 2013 · https://doi.org/10.1038/bjc.2013.634
Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as Susceptibility Loci for Systemic Lupus Erythematosus in a Large-Scale Multiracial Replication Study
The American Journal of Human Genetics · 2012 · https://doi.org/10.1016/j.ajhg.2012.02.023
Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
Modern Pathology · 2012 · https://doi.org/10.1038/modpathol.2012.36
Evolutionary Pathways in BRCA1-Associated Breast Tumors
Cancer Discovery · 2012 · https://doi.org/10.1158/2159-8290.cd-11-0325
BRAFV600E Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid Cancer
World Journal of Surgery · 2011 · https://doi.org/10.1007/s00268-011-1383-1
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus
Nature Genetics · 2011 · https://doi.org/10.1038/ng.766
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
Journal of Clinical Investigation · 2011 · https://doi.org/10.1172/jci44745
An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer
British Journal of Cancer · 2011 · https://doi.org/10.1038/bjc.2011.159
Heterogeneity for Stem Cell–Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
Clinical Cancer Research · 2010 · https://doi.org/10.1158/1078-0432.ccr-09-1532
Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype
Journal of Clinical Investigation · 2010 · https://doi.org/10.1172/jci40724
Promoter CpG island hypermethylation during breast cancer progression
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2010 · https://doi.org/10.1007/s00428-010-1013-6
Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis
Head & Neck · 2010 · https://doi.org/10.1002/hed.21518
Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system
Nephrology Dialysis Transplantation · 2004 · https://doi.org/10.1093/ndt/gfh633
Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary
Human Pathology · 2002 · https://doi.org/10.1053/hupa.2002.129422
Current projects
No projects listed.